Gujarat Themis Biosyn announced that the Board of Directors of the Company at its meeting held on 10 February 2024, has recommended a Interim dividend of Rs.0.75 per share (i.e.75%), subject to the approval of the shareholders.Powered by Capital Market - Live News

Net profit of Gujarat Themis Biosyn rose 32.62% to Rs 13.01 crore in the quarter ended December 2023 as against Rs 9.81 crore during the previous quarter ended December 2022. Sales rose 37.95% to Rs 38.86 crore in the quarter ended December 2023 as against Rs 28.17 crore during the previous quarter ended December 2022. ParticularsQuarter Ended�Dec. 2023Dec. 2022% Var. Sales38.8628.17 38 OPM %45.6842.99 - PBDT18.6713.85 35 PBT17.6913.19 34 NP13.019.81 33 Powered by Capital Market - Live News

Gujarat Themis Biosyn will hold a meeting of the Board of Directors of the Company on 10 February 2024.Powered by Capital Market - Live News

Net profit of Gujarat Themis Biosyn declined 32.94% to Rs 12.54 crore in the quarter ended September 2023 as against Rs 18.70 crore during the previous quarter ended September 2022. Sales declined 16.86% to Rs 39.65 crore in the quarter ended September 2023 as against Rs 47.69 crore during the previous quarter ended September 2022. ParticularsQuarter Ended�Sep. 2023Sep. 2022% Var. Sales39.6547.69 -17 OPM %42.4051.16 - PBDT17.7625.76 -31 PBT16.8825.18 -33 NP12.5418.70 -33 Powered by Capital Market - Live News

Gujarat Themis Biosyn will hold a meeting of the Board of Directors of the Company on 4 November 2023.Powered by Capital Market - Live News